Detalhe da pesquisa
1.
Novel repressor regulates insulin sensitivity through interaction with Foxo1.
EMBO J
; 31(10): 2275-95, 2012 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22510882
2.
Serum total bilirubin concentration in patients with type 2 diabetes as a possible biomarker of polyvascular disease.
Diabetol Int
; 9(2): 129-135, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30603360
3.
Serum bilirubin concentration is associated with eGFR and urinary albumin excretion in patients with type 1 diabetes mellitus.
J Diabetes Complications
; 29(8): 1223-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26234498
4.
Serum total bilirubin concentration is negatively associated with increasing severity of retinopathy in patients with type 2 diabetes mellitus.
J Diabetes Complications
; 29(2): 218-21, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25536865
5.
A Reduction of HbA1c after 3 Months Predicts 2-year Responsiveness to Sitagliptin Treatment.
Intern Med
; 54(23): 2981-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26631880
6.
C-peptide immunoreactivity index is associated with improvement of HbA1c: 2-Year follow-up of sitagliptin use in patients with type 2 diabetes.
Diabetes Res Clin Pract
; 108(3): 441-7, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795273
7.
Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: association with BNP and aldosterone levels.
Diabetes Res Clin Pract
; 106(3): 504-10, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25458339
8.
Loss of Pdk1-Foxo1 signaling in myeloid cells predisposes to adipose tissue inflammation and insulin resistance.
Diabetes
; 61(8): 1935-48, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22586579